Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska Alaska Tuberculosis Program Manual - Epidemiology - State of Alaska
Table 1: Persons at High Risk for Tuberculosis Infection and Progression to Tuberculosis Disease 4 For Tuberculosis Infection For Progression to Tuberculosis Disease 5 High-priority contacts such as housemates or coworkers or contacts of persons who have smearpositive pulmonary or laryngeal TB Infants, children, and adolescents exposed to adults in high-risk categories Recent immigrants (
When to Conduct Targeted Testing Alaska has a high prevalence of prior positive tuberculin skin tests among its highest risk populations – Alaska Natives, residents of the Southwest and Northern regions of the state, the homeless, and recent immigrants. Tuberculosis screening among these groups cannot be done using tuberculin skin testing. Instead, a combination of symptom screening and sputa collection is done. Please consult the Alaska TB Program at 907- 269-8000 for assistance in planning TB screening in these populations. Targeted testing programs should be conducted only among groups at high risk, and testing should be discouraged for groups at low risk. 6 High-risk groups include persons with increased risk for developing tuberculosis (TB) and those who have clinical conditions that are associated with an increased risk for progress of latent TB infection (LTBI) to TB disease. Factors that identify persons at high risk of LTBI infection and/or progressing to TB disease are listed in Table 1: Persons at High Risk for Tuberculosis Infection and Progression to Tuberculosis Disease. Evaluate high-risk patients for LTBI as specified in the Diagnosis of Latent Tuberculosis Infection section 7.7. Offer treatment of LTBI to infected persons, irrespective of age, who are considered to be at high risk for developing active TB. 7 See the Treatment of Latent Tuberculosis Infection section 8.4. Approaches to Increasing Targeted Testing and Treatment of Latent Tuberculosis Infection The Centers for Disease Control and Prevention (CDC) describes two approaches to increasing targeted testing and treatment of LTBI. To plan and implement programs for targeted testing and treatment of LTBI, follow the recommended approaches outlined below. 8 One approach is to promote clinic-based testing of persons who are under a clinician’s care for a medical condition (e.g., human immunodeficiency virus [HIV] infection or diabetes mellitus) that also confers a risk for acquiring TB. This approach depends on a person’s risk profile for TB. 9 A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L Targeted Testing for Latent Tuber culosis Infection 3.6 R e v i s e d N o v e m b e r 2 0 1 2
- Page 1 and 2: Alaska Tuberculosis Program Manual
- Page 3 and 4: Purpose............................
- Page 5 and 6: Monthly assessment of adherence ...
- Page 7 and 8: When to Expand a Contact Investigat
- Page 9 and 10: Introduction CONTENTS About the Ala
- Page 11 and 12: How to Use This Manual Portable Doc
- Page 13 and 14: Printing To access the print dialog
- Page 15 and 16: Abbreviations Refer to the list bel
- Page 17 and 18: QFT QuantiFERON ® -TB test QFT-G Q
- Page 19 and 20: Alaska Statutes and Regulations on
- Page 21 and 22: National and State Program Objectiv
- Page 23 and 24: Indicator 3 Thorough contact invest
- Page 25 and 26: National Standards and Recommendati
- Page 27 and 28: Roles and Responsibilities Contact
- Page 29 and 30: Local Public Health Agencies Table
- Page 31 and 32: Resources and References Resources
- Page 33 and 34: Introduction Purpose Use this secti
- Page 35 and 36: Contact investigation: Collecting,
- Page 37 and 38: Reporting Tuberculosis Detecting an
- Page 39 and 40: Prompt reporting (prior to culture
- Page 41 and 42: Use the Infectious Disease Report F
- Page 43 and 44: Data Collection Forms The following
- Page 45 and 46: Genotyping Genotyping is a useful t
- Page 47 and 48: References 1 ATS, CDC, IDSA. Contro
- Page 49 and 50: Introduction Purpose Use this secti
- Page 51: child or a person acting on behalf
- Page 55 and 56: Alaska Program Standards for Health
- Page 57 and 58: B Notifications CONTENTS Introducti
- Page 59 and 60: Table 1: NUMBERS OF FOREIGN-BORN PE
- Page 61 and 62: chest radiograph and if sputum AFB
- Page 63 and 64: Follow-up of B1 and B2 Tuberculosis
- Page 65 and 66: Evaluation of B1, B2, and B Tubercu
- Page 67 and 68: Treatment Prescribe medications as
- Page 69 and 70: 12 Centers for Disease Control and
- Page 71 and 72: Introduction Purpose Use this secti
- Page 73 and 74: Tuberculosis Classification System
- Page 75 and 76: Table 2: PERSONS AT HIGH RISK FOR T
- Page 77 and 78: Table 3: WHEN TO SUSPECT PULMONARY
- Page 79 and 80: Diagnosis of Tuberculosis Disease T
- Page 81 and 82: 1. Exposure to Infectious TB: Ask p
- Page 83 and 84: Physical Examination A physical exa
- Page 85 and 86: For more information on chest radio
- Page 87 and 88: Laboratories should report positive
- Page 89 and 90: Guidelines for preventing the trans
- Page 91 and 92: 50 CDC. National plan for reliable
- Page 93 and 94: Introduction Purpose The overall go
- Page 95 and 96: Basic Treatment Principles Follow t
- Page 97 and 98: Treatment Regimens and Dosages Use
- Page 99 and 100: Table 3: FOUR TREATMENT REGIMENS FO
- Page 101 and 102: † 4 Table 4: DOSES*OF FIRST-LINE
When to Conduct Targeted Testing<br />
<strong>Alaska</strong> has a high prevalence <strong>of</strong> prior positive tuberculin skin tests among its highest risk<br />
populations – <strong>Alaska</strong> Natives, residents <strong>of</strong> the Southwest and Northern regions <strong>of</strong> the<br />
state, the homeless, and recent immigrants. <strong>Tuberculosis</strong> screening among these<br />
groups cannot be done using tuberculin skin testing. Instead, a combination <strong>of</strong> symptom<br />
screening and sputa collection is done. Please consult the <strong>Alaska</strong> TB <strong>Program</strong> at 907-<br />
269-8000 for assistance in planning TB screening in these populations.<br />
Targeted testing programs should be conducted only among groups at high risk, and<br />
testing should be discouraged for groups at low risk. 6 High-risk groups include persons<br />
with increased risk for developing tuberculosis (TB) and those who have clinical<br />
conditions that are associated with an increased risk for progress <strong>of</strong> latent TB infection<br />
(LTBI) to TB disease.<br />
Factors that identify persons at high risk <strong>of</strong> LTBI infection and/or<br />
progressing to TB disease are listed in Table 1: Persons at High Risk for<br />
<strong>Tuberculosis</strong> Infection and Progression to <strong>Tuberculosis</strong> Disease.<br />
Evaluate high-risk patients for LTBI as specified in the Diagnosis <strong>of</strong> Latent<br />
<strong>Tuberculosis</strong> Infection section 7.7.<br />
Offer treatment <strong>of</strong> LTBI to infected persons, irrespective <strong>of</strong> age, who are<br />
considered to be at high risk for developing active TB. 7 See the Treatment<br />
<strong>of</strong> Latent <strong>Tuberculosis</strong> Infection section 8.4.<br />
Approaches to Increasing Targeted Testing<br />
and Treatment <strong>of</strong> Latent <strong>Tuberculosis</strong> Infection<br />
The Centers for Disease Control and Prevention (CDC) describes two approaches to<br />
increasing targeted testing and treatment <strong>of</strong> LTBI. To plan and implement programs for<br />
targeted testing and treatment <strong>of</strong> LTBI, follow the recommended approaches outlined<br />
below. 8<br />
One approach is to promote clinic-based testing <strong>of</strong> persons who are under a clinician’s<br />
care for a medical condition (e.g., human immunodeficiency virus [HIV] infection or<br />
diabetes mellitus) that also confers a risk for acquiring TB. This approach depends on a<br />
person’s risk pr<strong>of</strong>ile for TB. 9<br />
A L A S K A T U B E R C U L O S I S P R O G R A M M A N U A L Targeted Testing for Latent Tuber culosis Infection 3.6<br />
R e v i s e d N o v e m b e r 2 0 1 2